KURA insider trading — Kura Oncology, Inc.
Over the last 90 days, insiders at Kura Oncology, Inc. (KURA) made 2 open-market purchases worth $2.35M and 6 open-market sales worth $1.06M, making them net buyers by $1.29M. The largest purchase was by Wilson Troy Edward (President and CEO), who bought 100,000 shares for $1.24M on Aug 24, 2026. The largest sale was by Leoni Mollie (Chief Medical Officer), who sold 28,802 shares for $310K on Sep 29, 2026.
Updated Oct 16, 2026.
Recent KURA insider transactions
Every Form 4 filed by Kura Oncology, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Leoni Mollie | Chief Medical Officer | S · Sale | Direct | 28,802 | $10.75 | $310K | Form 4 |
| Sep 29, 2026 | Powl Brian T. | Chief Commercial Officer | S · Sale | Direct | 15,430 | $10.75 | $166K | Form 4 |
| Sep 29, 2026 | Ford Kathleen | Chief Operating Officer | S · Sale · 10b5-1 | Direct | 3,668 | $10.75 | $39K | Form 4 |
| Sep 28, 2026 | Leoni Mollie | Chief Medical Officer | S · Sale | Direct | 12,448 | $10.50 | $131K | Form 4 |
| Sep 28, 2026 | Powl Brian T. | Chief Commercial Officer | S · Sale | Direct | 17,020 | $10.53 | $179K | Form 4 |
| Sep 28, 2026 | Bair Teresa Brophy | Chief Legal Officer | S · Sale · 10b5-1 | Direct | 8,442 | $10.50 | $89K | Form 4 |
| Sep 28, 2026 | Doyle Thomas James | SVP, Finance & Accounting | S · Sale | Direct | 4,607 | $10.50 | $48K | Form 4 |
| Sep 28, 2026 | Ford Kathleen | Chief Operating Officer | S · Sale · 10b5-1 | Direct | 6,906 | $10.50 | $72K | Form 4 |
| Sep 24, 2026 | Burrows Francis | Chief Scientific Officer | M · Option exercise | Direct | 30,000 | $6.15 | $184K | Form 4 |
| Sep 24, 2026 | Burrows Francis | Chief Scientific Officer | S · Sale | Direct | 20,726 | $10.83 | $225K | Form 4 |
| Aug 24, 2026 | Wilson Troy Edward | President and CEO | P · Purchase | Indirect | 100,000 | $12.39 | $1.24M | Form 4 |
| Aug 21, 2026 | Powl Brian T. | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 4,345 | $11.89 | $52K | Form 4 |
| Aug 19, 2026 | Bair Teresa Brophy | Chief Legal Officer | S · Sale · 10b5-1 | Direct | 31,487 | $12.63 | $398K | Form 4 |
| Aug 17, 2026 | Wilson Troy Edward | President and CEO | P · Purchase | Indirect | 100,000 | $11.12 | $1.11M | Form 4 |
KURA insider trading FAQ
Are insiders buying KURA stock?
Yes. In the last 90 days, Kura Oncology, Inc. insiders made 2 open-market purchases totaling $2.35M, and 6 open-market sales totaling $1.06M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading KURA?
Recent buyers: Wilson Troy Edward. Recent sellers: Burrows Francis, Doyle Thomas James, Leoni Mollie, Powl Brian T..
Where does KURA insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.